People with major depressive disorder have a new treatment option through the SPRAVATO nasal spray

Lucy Williams
Updated May 24 2022 - 11:26am, first published 11:15am
PROGRESS: Melbourne University Professor Mal Hopwood has welcomed the new treatment for major depressive disorder (MDD) - SPRAVATO - which may soon be available to Australians. Picture: SUPPLIED
PROGRESS: Melbourne University Professor Mal Hopwood has welcomed the new treatment for major depressive disorder (MDD) - SPRAVATO - which may soon be available to Australians. Picture: SUPPLIED

Australians suffering from major depressive disorder (MDD) may soon be able to access a new treatment in the form of a nasal spray.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options
Lucy Williams

Lucy Williams

Journalist

Journalist with an interest in telling regional and rural stories, and covering the diverse array of topics that matter to the people of Bendigo.

Get the latest Bendigo news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.